Growth Metrics

Cytosorbents (CTSO) EBT Margin Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -305.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -9.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -222.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -176.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 329.00
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 3,352.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3,352.00
Dec 31, 2025 -5,066.00
Sep 30, 2025 11,277.00
Jun 30, 2025 8,406.00
Mar 31, 2025 8,622.00
Dec 31, 2024 -802.00
Sep 30, 2024 3,350.00
Jun 30, 2024 -796.00
Mar 31, 2024 -2,841.00
Dec 31, 2023 18,267.00
Sep 30, 2023 -9,638.00
Jun 30, 2023 -3,604.00
Mar 31, 2023 -3,787.00
Dec 31, 2022 4,806.00
Sep 30, 2022 -3,745.00
Jun 30, 2022 -7,114.00
Mar 31, 2022 -909.00
Dec 31, 2021 590.00
Sep 30, 2021 -1,331.00
Jun 30, 2021 6,224.00
Mar 31, 2021 2,123.00
Dec 31, 2020 6,719.00
Sep 30, 2020 4,575.00
Jun 30, 2020 1,937.00
Mar 31, 2020 932.00
Dec 31, 2019 10,158.00
Sep 30, 2019 -2,223.00
Jun 30, 2019 7,831.00
Mar 31, 2019 737.00
Dec 31, 2018 10,945.00
Sep 30, 2018 15,960.00
Jun 30, 2018 -24,994.00
Mar 31, 2018 59,179.00
Dec 31, 2017 53,354.00
Sep 30, 2017 7,519.00
Jun 30, 2017 13,226.00
Mar 31, 2017 4,282.00
Dec 31, 2016 -11,056.00
Sep 30, 2016 5,175.00
Jun 30, 2016 97,050.00
Mar 31, 2016 82,358.00
Dec 31, 2015 84,809.00
Sep 30, 2015 455,436.00
Jun 30, 2015 224,342.00
Mar 31, 2015 218,801.00
Dec 31, 2014 270,185.00